Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure

被引:184
作者
MacAllister, RJ
Rambausek, MH
Vallance, P
Williams, D
Hoffmann, KH
Ritz, E
机构
[1] UCL, SCH MED, CRUCIFORM PROJECT, CTR CLIN PHARMACOL, LONDON W1N 8AA, ENGLAND
[2] RUPRECHT KARLS UNIV HEIDELBERG, DEPT INTERNAL MED, HEIDELBERG, GERMANY
关键词
uraemia; dialysis; NO synthase; ADMA; SDMA;
D O I
10.1093/oxfordjournals.ndt.a027213
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
N-G N-G dimethyl-L-arginine (asymmetric dimethyl-l-arginine; ADMA) and (NN)-N-G'(G) dimethyl-L-arginine (symmetric dimethyl-L-arginine; SDMA) are naturally occurring analogues of L-arginine, the substrate for nitric oxide (NO) synthesis. ADMA is a potent inhibitor of NO synthesis, and accumulates in the plasma of patients with renal failure. However the precise concentration of ADMA and SDMA in renal patients is still controversial. This study was performed to measure plasma ADMA and SDMA concentrations by two different HPLC techniques in nine healthy controls and 10 uraemic subjects, and to investigate the effects of haemodialysis. In controls, the mean (+/- SEM) plasma concentrations of ADMA and SDMA were 0.36 +/- 0.09 and 0.39 +/- 0.05 mu mol/l respectively, yielding an ADMA/SDMA ratio of 1.2 +/- 0.17. In uraemic patients, the plasma concentrations of ADMA and SDMA were 0.9 +/- 0.08 mu mol/l (P < 0.001 compared to controls) and 3.4 +/- 0.3 mu mol/l (P < 0.001 compared to controls) with an ADMA/SDMA ratio of 0.27 +/- 0.015 (P < 0.001). In the course of one 4 h haemodialysis session, ADMA concentrations decreased from 0.99 +/- 0.13 to 0.77 +/- 0.3 mu mol/l and SDMA concentrations from 3.38 +/- 0.44 to 2.27 +/- 0.21 mu mol/l. The plasma ADMA/creatinine ratio tended to increase from 1.26 +/- 0.20 x 10(-3) to 2.01 +/- 0.41 x 10(-3). It is concluded that there is a modest (3-fold) but definite increase in plasma ADMA concentration in uraemic patients compared to controls. SDMA accumulates to a greater degree (8-fold increase) and more closely parallels creatinine concentration than ADMA. The change in the ADMA/SDMA ratio is not accounted for by greater renal or dialysis clearance of ADMA, and, even though alternative explanations are not excluded, greater metabolism of ADMA than SDMA is the most likely explanation Although small in magnitude, the increase in ADMA concentration might be biologically significant.
引用
收藏
页码:2449 / 2452
页数:4
相关论文
共 16 条
[1]  
ANDERSTAM B, 1994, JASN, V5, pA572
[2]  
ANORE A, 1995, J AM SOC NEPHROL, V6, P1278
[3]  
ARESE M, 1995, NEPHROL DIAL TRANSPL, V10, P1386
[4]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC SEPARATION WITH ELECTROCHEMICAL DETECTION OF AMINO-ACIDS FOCUSING ON NEUROCHEMICAL APPLICATION [J].
CANEVARI, L ;
VIEIRA, R ;
ALDEGUNDE, M ;
DAGANI, F .
ANALYTICAL BIOCHEMISTRY, 1992, 205 (01) :137-142
[5]   CHRONIC INHIBITION OF NITRIC-OXIDE PRODUCTION ACCELERATES NEOINTIMA FORMATION AND IMPAIRS ENDOTHELIAL FUNCTION IN HYPERCHOLESTEROLEMIC RABBITS [J].
CAYATTE, AJ ;
PALACINO, JJ ;
HORTEN, K ;
COHEN, RA .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (05) :753-759
[6]   DETECTION OF N-G,N-G-DIMETHYLARGININE DIMETHYLAMINOHYDROLASE IN HUMAN TISSUES USING A MONOCLONAL-ANTIBODY [J].
KIMOTO, M ;
WHITLEY, GS ;
TSUJI, H ;
OGAWA, T .
JOURNAL OF BIOCHEMISTRY, 1995, 117 (02) :237-238
[7]   NITRIC-OXIDE INCREASES RENAL BLOOD-FLOW BY INTERACTING WITH THE SYMPATHETIC NERVOUS-SYSTEM [J].
KUMAGAI, K ;
SUZUKI, H ;
ICHIKAWA, M ;
JIMBO, M ;
MURAKAMI, M ;
RYUZAKI, M ;
SARUTA, T .
HYPERTENSION, 1994, 24 (02) :220-226
[8]   EFFECTS OF GUANIDINO AND UREMIC COMPOUNDS ON NITRIC-OXIDE PATHWAYS [J].
MACALLISTER, RJ ;
WHITLEY, GSJ ;
VALLANCE, P .
KIDNEY INTERNATIONAL, 1994, 45 (03) :737-742
[9]   METABOLISM OF METHYLARGININES BY HUMAN VASCULATURE - IMPLICATIONS FOR THE REGULATION OF NITRIC-OXIDE SYNTHESIS [J].
MACALLISTER, RJ ;
FICKLING, SA ;
WHITLEY, GS ;
VALLANCE, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (01) :43-48
[10]   ENHANCED NITRIC-OXIDE SYNTHESIS IN UREMIA - IMPLICATIONS FOR PLATELET DYSFUNCTION AND DIALYSIS HYPOTENSION [J].
NORIS, M ;
BENIGNI, A ;
BOCCARDO, P ;
AIELLO, S ;
GASPARI, F ;
TODESCHINI, M ;
FIGLIUZZI, M ;
REMUZZI, G .
KIDNEY INTERNATIONAL, 1993, 44 (02) :445-450